GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Allakos Inc (FRA:37Z) » Definitions » Accounts Payable

Allakos (FRA:37Z) Accounts Payable : €14.49 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Allakos Accounts Payable?

Allakos's Accounts Payable for the quarter that ended in Mar. 2024 was €14.49 Mil.

Allakos's quarterly Accounts Payable increased from Sep. 2023 (€0.86 Mil) to Dec. 2023 (€1.62 Mil) and increased from Dec. 2023 (€1.62 Mil) to Mar. 2024 (€14.49 Mil).

Allakos's annual Accounts Payable declined from Dec. 2021 (€12.12 Mil) to Dec. 2022 (€4.56 Mil) and declined from Dec. 2022 (€4.56 Mil) to Dec. 2023 (€1.62 Mil).


Allakos Accounts Payable Historical Data

The historical data trend for Allakos's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allakos Accounts Payable Chart

Allakos Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial 5.37 11.48 12.12 4.56 1.62

Allakos Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.50 3.98 0.86 1.62 14.49

Allakos Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Allakos Accounts Payable Related Terms

Thank you for viewing the detailed overview of Allakos's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Allakos (FRA:37Z) Business Description

Traded in Other Exchanges
Address
825 Industrial Road, Suite 500, San Carlos, CA, USA, 94070
Allakos Inc is a clinical-stage company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory, and proliferative diseases. The company's lead program, AK002, an antibody that targets Siglec-8, an inhibitory receptor found on eosinophils and mast cells. In preclinical and clinical studies, AK002 has been shown to deplete eosinophils and inhibit mast cells.

Allakos (FRA:37Z) Headlines

No Headlines